Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25
The Journal of Infectious Diseases · 31.10.2026
DOI: 10.1093/infdis/jiag538 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 31.10.2026. Verfasst von Jessica R Meeker und 23 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Gefördert von: NCIRD CDC HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Influenza B vaccine effectiveness (VE) has varied by season, lineage, antigenic drift, and vaccine composition. After B/Yamagata detection ceased globally, trivalent vaccines containing B/Victoria were reintroduced in 2024–25. We evaluated influenza B circulation and VE across eight analyzed seasons spanning this transition.
Methods
Ambulatory patients aged ≥6 months with acute respiratory illness were enrolled at U.S. Flu VE Network sites during eight influenza seasons from 2016–17 through 2024–25; 2020–21 was excluded because influenza circulation was negligible. Participants were tested by RT-PCR. Lineage-specific VE was estimated using a test-negative design and logistic regression adjusted for age, sex, race/ethnicity, calendar time, and study site. VE was reported for season-lineage strata with ≥50 influenza B cases.
Results
Among 65,773 participants, 3,629 influenza B cases were included in lineage-specific VE analyses (1,507 B/Yamagata; 2,122 B/Victoria). Six of 10 season-lineage strata met the reporting threshold. B/Victoria VE was 58% (95% CI, 28%–77%) in 2016–17, 51% (43%–57%) in 2019–20, 78% (71%–84%) in 2023–24, and 39% (14%–56%) in 2024–25. B/Yamagata VE was 55% (46%–63%) in 2016–17 and 49% (40%–56%) in 2017–18.
Conclusions
Influenza vaccines protected against medically attended outpatient influenza B illness, although VE varied by season. Continued VE monitoring and genetic surveillance are needed to detect emerging influenza B viruses and inform vaccine strain selection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- University of Michigan School of Public Health, Ann Arbor, MI, USA.
- Henry Ford Health, Department of Public Health Sciences, Detroit, MI, USA.
- Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
- Baylor Scott & White Health, Temple, TX, USA.
- Baylor College of Medicine, Temple, TX, USA.
ORCID-Profile: Jessica R Meeker, Ashley M Price, Emily Martin, Ivana Vaughn, C Hallie Phillips, Manjusha J Gaglani, Huong Q Nguyen, Vel Murugan, Lora Nordstrom, Elie Saade, Kiran Faryar, Richard K Zimmerman, Natalie A B Bontrager, Sascha Ellington
Förderung
- NCIRD CDC HHS
- NCATS NIH HHS
Zitieren
APA
Meeker, J. R., Price, A. M., Martin, E., Vaughn, I., Wernli, K. J., Phillips, C. H., Gaglani, M. J., Raiyani, C., Nguyen, H. Q., King, J. P., House, S., Mills, J., Murugan, V., Nordstrom, L., Saade, E., Faryar, K., Zimmerman, R. K., Moehling Geffel, K., Walter, E. B., …, & US Flu VE Network Investigators (2026). Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag538
Vancouver
Meeker JR, Price AM, Martin E, Vaughn I, Wernli KJ, Phillips CH, et al. Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag538
BibTeX
@article{Meeker2026,
author = {Meeker, Jessica R and Price, Ashley M and Martin, Emily and Vaughn, Ivana and Wernli, Karen J and Phillips, C Hallie and Gaglani, Manjusha J and Raiyani, Chandni and Nguyen, Huong Q and King, Jennifer P and House, Stacey and Mills, Jamie and Murugan, Vel and Nordstrom, Lora and Saade, Elie and Faryar, Kiran and Zimmerman, Richard K and Moehling Geffel, Krissy and Walter, Emmanuel B and Bontrager, Natalie A B and Chung, Jessie R and Flannery, Brendan and Ellington, Sascha and US Flu VE Network Investigators, US Flu VE Network Investigators},
title = {Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016–17 Through 2024–25},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag538}
}
EUVIMED